JENNIFER SWAIN: Open Payments
NPI 1992437602 · ELKHART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 38 payments from 13 companies in 2025. Trend: 2023 $1,535 · 2024 $1,805 · 2025 $814
Food & beverage: $814
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $182 |
| Merck Sharp & Dohme LLC | 6 | $137 |
| Alnylam Pharmaceuticals Inc. | 4 | $108 |
| AtriCure, Inc. | 1 | $90 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $87 |
| E.R. Squibb & Sons, L.L.C. | 3 | $42 |
| Boston Scientific Corporation | 1 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Abbott Laboratories | 1 | $25 |
| CVRx, Inc. | 1 | $21 |
Products named: LEQVIO, ONPATTRO, VERQUVO, ATRICLIP LAA EXCLUSION SYSTEM, LifeVest, CAPVAXIVE, CDS - MCT/CEM Monitoring, JARDIANCE.
Industry payments across IN — which companies pay providers there.
